Media stories about Quintiles Transitional Holdings (NYSE:Q) have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Quintiles Transitional Holdings earned a news sentiment score of 0.14 on Accern’s scale. Accern also assigned media headlines about the medical research company an impact score of 46.5256299053486 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Here are some of the media headlines that may have effected Accern Sentiment’s rankings:

A number of research firms have commented on Q. Barclays PLC set a $100.00 price target on shares of Quintiles Transitional Holdings and gave the stock a “buy” rating in a report on Friday, August 4th. Zacks Investment Research lowered shares of Quintiles Transitional Holdings from a “buy” rating to a “hold” rating in a research note on Tuesday, August 1st. Jefferies Group LLC reaffirmed a “hold” rating and issued a $94.00 price objective on shares of Quintiles Transitional Holdings in a research note on Friday, August 4th. Stifel Nicolaus reaffirmed a “hold” rating and issued a $92.00 price objective (up from $87.00) on shares of Quintiles Transitional Holdings in a research note on Friday, August 4th. Finally, William Blair raised shares of Quintiles Transitional Holdings from a “market perform” rating to an “outperform” rating and raised their price objective for the company from $70.10 to $93.42 in a research note on Friday, August 4th. Eleven investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $89.94.

Quintiles Transitional Holdings (Q) traded down 2.81% during trading on Thursday, hitting $87.57. 1,364,169 shares of the stock traded hands. Quintiles Transitional Holdings has a 52-week low of $70.10 and a 52-week high of $93.53. The firm has a 50-day moving average price of $90.13 and a 200 day moving average price of $83.39. The company has a market cap of $18.96 billion, a P/E ratio of 253.83 and a beta of 0.64.

Quintiles Transitional Holdings (NYSE:Q) last issued its quarterly earnings data on Thursday, August 3rd. The medical research company reported $1.09 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.04. Quintiles Transitional Holdings had a net margin of 0.82% and a return on equity of 14.23%. The firm had revenue of $1.97 billion for the quarter, compared to analysts’ expectations of $1.96 billion. During the same quarter in the prior year, the business earned $0.93 EPS. The business’s quarterly revenue was up 68.7% on a year-over-year basis. On average, equities analysts expect that Quintiles Transitional Holdings will post $4.58 EPS for the current year.

Quintiles Transitional Holdings declared that its Board of Directors has authorized a stock buyback program on Wednesday, May 24th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the medical research company to buy up to 5.4% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s leadership believes its shares are undervalued.

In other Quintiles Transitional Holdings news, Director John G. Danhakl sold 761,143 shares of the firm’s stock in a transaction that occurred on Tuesday, May 30th. The shares were sold at an average price of $84.01, for a total transaction of $63,943,623.43. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Jack M. Greenberg sold 6,092 shares of the firm’s stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $82.50, for a total transaction of $502,590.00. Following the sale, the director now owns 2,930 shares in the company, valued at approximately $241,725. The disclosure for this sale can be found here. Insiders sold a total of 8,850,560 shares of company stock worth $744,110,641 in the last quarter. Company insiders own 6.40% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at

About Quintiles Transitional Holdings

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Insider Buying and Selling by Quarter for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with's FREE daily email newsletter.